drugset / Trial / NCT00232375
Intervention to Preserve Beta-Cell Function in GAD Ab-Positive Diabetes
RandomizedParallel-groupOpen-labelPrevention
Summary
We tested the hypothesis that insulin therapy rather than sulfonylurea (SU) treatment has a preferable outcome to reverse or preserve beta cell function in the patients with diabetes that is called slowly progressive insulin-dependent (type 1) diabetes (SPIDDM) or latent autoimmune diabetes in adult (LADA).
Timeline
- Start
- 1996-01
- Primary completion
- —
- Completion
- 2005-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | — | — |
Indications
No indication recorded.